SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-009562
Filing Date
2022-02-14
Accepted
2022-02-14 19:54:34
Documents
2
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 SUBMISSION doc5.html 5  
1 FORM 5 SUBMISSION doc5.xml 5 8404
2 POA DOCUMENT poa.txt EX-24 3541
  Complete submission text file 0001209191-22-009562.txt   13496
Mailing Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102 206-732-2133
Neoleukin Therapeutics, Inc. (Issuer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 21823 30TH DRIVE SE BOTHELL WA 98021
Business Address
DRACHMAN JONATHAN G (Reporting) CIK: 0001588467 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-36327 | Film No.: 22636469